We are live on ! Find out more
CH

CVS Health Portfolio holdings

AUM $225M
1-Year Est. Return 8.77%
This Fund
S&P 500
This Quarter Est. Return
-9.44%
1 Year Est. Return
+8.77%
3 Year Est. Return
+48.72%
5 Year Est. Return
10 Year Est. Return
AUM
$149M
AUM Growth
+$34.6M
Cap. Flow
+$47.5M
Cap. Flow %
31.89%
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
Reduced
1
Closed

Top Sells

Rank Stock Value
1
LMDXW
LumiraDx Limited Warrant
LMDXW
+$55.4K

Sector Composition

Rank Sector Weight
1 Healthcare 0.57%
2 Financials 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDV
1
iShares Core High Dividend ETF
HDV
$15.3B
$66.8M 44.83%
3,122,680
LMDXW
2
DELISTED
LumiraDx Limited Warrant
LMDXW
$33.2M 22.29%
5,531,366
-43,047
-0.8% -$55.4K
VYM icon
3
Vanguard High Dividend Yield ETF
VYM
$83.4B
$24.1M 16.21%
+215,000
New +$24M
SCHD icon
4
Schwab US Dividend Equity ETF
SCHD
$111B
$23.7M 15.89%
+900,000
New +$23.6M
HCAT icon
5
Health Catalyst
HCAT
$127M
$843K 0.57%
32,273
PRU icon
6
Prudential Financial
PRU
$42.2B
$317K 0.21%
2,683

Similar funds

CVS Health's Q1 2022 Portfolio in Review

As of Q1 2022, CVS Health held 6 positions worth $149M, up 30% from $114M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

CVS Health deployed $47.5M of net new capital in Q1 2022, opening 2 new positions. Its largest new stake was Vanguard High Dividend Yield ETF: 215,000 shares worth $24.1M.

By sector, the portfolio is most concentrated in Healthcare at 0.57% of assets, down from 1.1% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was LumiraDx Limited Warrant, an estimated $55.4K trimmed.

  • CVS Health's largest Q1 2022 buy was Vanguard High Dividend Yield ETF: 215,000 shares worth $24.1M.
  • CVS Health's biggest Q1 2022 reduction was LumiraDx Limited Warrant, cutting an estimated $55.4K.
  • CVS Health's ten largest holdings make up 100% of its $149M portfolio in Q1 2022.
  • CVS Health opened 2 new positions and closed 0 in Q1 2022.
  • CVS Health's portfolio value rose 30% quarter-over-quarter to $149M.

Based on CVS Health's 13F filing for Q1 2022, filed 13 May 2022.